About Us

Flagship is a multi-disciplinary team of pathologists, biologists, analysts, software engineers, and technicians who are committed to creating successful approaches which match patients with life-saving drugs.

Helping Biomedical Companies
Change Lives.

Flagship is the only company capable of creating a quantitative image analysis solution for your exploratory biomarker efforts and directly implement the same solution into a companion diagnostic device ready for regulatory submission and market approval.

Our team consists of experienced:

  • Research & Clinical Pathologists
  • Expert PhD Biologists
  • Certified Histotechnicians
  • Skilled Image Analysis Scientists
  • In-house Statisticians & Programmers
  • Quality Assurance & Regulatory Experts

Our Leadership

G. David Young, DVM, DACVP, DABT

G. David Young, DVM, DACVP, DABT

President and CEO

Holger Lange, PhD

Holger Lange, PhD

Chief Technology Officer

Joseph Krueger, PhD

Joseph Krueger, PhD

Chief Scientific Officer

Trevor Johnson, MS

Trevor Johnson, MS

Chief Operating Officer

Dean Northey

Dean Northey

Chief Financial Officer

Our Facilities

Flagship has been creating quantitative tissue endpoints for clinical trials since 2009. We have dozens of experts focused on delivering success in our 22,000 square foot wet assay and image analysis laboratories.

State of the art histology laboratory

State of the art histology laboratory

Advanced tissue image analysis laboratory

Advanced tissue image analysis laboratory

High-throughput analysis capabilities

High-throughput analysis capabilities

Brightfield and fluorescent whole slide scanning

Brightfield and fluorescent whole slide scanning

Flexibility on multiple platforms

Flexibility on multiple platforms

CLIA certified laboratory

CLIA certified laboratory

Success Stories

Our technology enables us to create custom image analysis approaches for even the most difficult pathology endpoints. Our software is developed through our experience in real world applications, supported by an internal research and development team, and is backed by our intellectual property portfolio.

Professional Organizations

We are involved and contribute to the advancement of our field through professional participation.

Over 100 pharmaceutical, biotech, and medical device firms rely on Flagship's technology for success.

Our combination of biology, pathology, and technology has advanced emerging therapies in over 400 studies since 2009.